China’s laparoscopic surgical robotics industry is entering a new phase of product iteration.

After an earlier stage focused on breaking import dependence and establishing whether domestic surgical robots could perform procedures at all, competition is increasingly moving toward a more detailed question: how well can a robotic platform adapt to specific procedures and real clinical workflows?

For surgeons, attention is shifting toward practical details such as instrument coordination, procedure-specific tools, energy-device integration and the ability to operate effectively in deep and confined surgical fields.

At the 2026 Annual Meeting of the Chinese Society of Surgery, WEISEBOT, the surgical robotics platform strategically invested in by KANGJI Medical, presented the latest development of its laparoscopic surgical robotic system and supporting instruments.

For specialties such as hepatobiliary, pancreatic and gastrointestinal surgery, complex procedures require more than a robotic arm capable of reproducing a surgeon’s movements. They also place demands on energy instruments, tissue handling, multi-instrument coordination and access to deep anatomical spaces.

WEISEBOT’s recent product development reflects this shift. The company is expanding its instrument portfolio and optimizing system-level coordination around actual surgical scenarios, with the aim of allowing the same robotic platform to better support different subspecialties and procedures.

01 | Beyond the Robotic Arm: Diverse General Surgery Procedures Are Driving a Broader Instrument System

Compared with some other surgical specialties, general surgery covers a particularly wide range of procedures.

Hepatobiliary and pancreatic surgery, gastrointestinal surgery and other procedures can differ significantly in anatomy, operating space and surgical technique. This creates different requirements for cutting, dissection, coagulation, grasping and suturing instruments.

For a surgical robotic platform, simply providing a set of basic robotic instruments is therefore not sufficient.

The instrument system needs to support different tissue characteristics and procedural steps, while also allowing surgeons to switch between instruments and coordinate them efficiently during surgery.

This has pushed WEISEBOT to expand its supporting instrument portfolio around actual procedural needs.

The company’s approach is to move away from designing individual instruments in isolation and instead consider how different instruments work together within a complete robotic surgical workflow.

For example, liver and pancreatic procedures frequently involve complex vascular and tissue dissection, while gastrointestinal surgery places different demands on exposure, traction, tissue handling and reconstruction.

The corresponding robotic instruments therefore need to differ in jaw design, working length, articulation and energy capabilities.

WEISEBOT is using these differences as the basis for instrument development, with the goal of allowing one robotic platform to cover a wider range of general surgical applications.

02 | Energy Instruments: Continued Domestic Development Around Robotic Surgery

Energy instruments are another important part of procedure adaptation.

In laparoscopic surgery, ultrasonic and electrosurgical devices are routinely used for tissue dissection, vessel sealing, coagulation and cutting. When these tools are incorporated into a robotic platform, their design also needs to match the robotic control system, instrument architecture and operating workflow.

WEISEBOT has been developing its own supporting energy instruments rather than treating them simply as external accessories.

The company’s product development includes instruments intended to address the different energy requirements of robotic general surgery.

At an academic session, the application of the ultrasonic scalpel in robotic surgery was discussed from the perspective of clinical use.

For robotic procedures, energy instruments need to provide stable tissue handling while working within the spatial and control constraints of the robotic platform.

Their value is therefore not determined only by energy output. Mechanical structure, articulation, instrument length, visibility at the operative site and coordination with other robotic instruments can all affect usability.

For domestic surgical robotics companies, bringing energy tools into the same development framework as the robot itself can also reduce dependence on external instrument ecosystems and allow products to be optimized more directly around the platform.

03 | Bipolar Sealing Combinations: From Individual Instruments to Procedure-Oriented System Configuration

Another direction in WEISEBOT’s instrument development is the combination of bipolar instruments with other robotic tools.

Different procedural steps require different forms of tissue handling.

A single instrument may be suitable for one stage of surgery but cannot cover dissection, coagulation, traction and reconstruction throughout an entire procedure.

For this reason, robotic surgery increasingly depends on instrument combinations rather than one “all-purpose” tool.

WEISEBOT is developing its instrument system around this logic.

Bipolar coagulation and sealing instruments can be used together with graspers, scissors and other articulated robotic instruments according to the needs of different procedures.

This allows the surgeon to select instrument combinations based on anatomy and surgical steps instead of adapting the procedure to a limited instrument set.

The underlying shift is from asking “what instruments does the robot have?” toward asking “what instrument combination does this procedure require?”

For general surgery in particular, where one platform may be used in hepatobiliary, pancreatic, gastrointestinal and other procedures, this system-level approach becomes increasingly important.

04 | Extended Curved Scissors: Addressing Deep Surgical Fields

Instrument geometry also becomes more important when robotic surgery moves into deeper anatomical spaces.

WEISEBOT has developed extended curved scissors for scenarios in which conventional instrument dimensions or angles may limit access.

In deep operative fields, the distance from the trocar to the target anatomy is greater, while the available working angle can be narrower.

Instrument length, distal articulation and the geometry of the cutting end can therefore directly affect whether the surgeon can reach and dissect the target tissue efficiently.

The extended curved design is intended to provide additional reach while preserving the wristed movement of the robotic instrument.

For the surgeon, the goal is not simply to make an instrument longer, but to maintain controllability and an appropriate cutting angle after the instrument reaches a deeper anatomical location.

This type of instrument development reflects a broader change in domestic surgical robotics: product iteration is increasingly being driven by specific procedural details rather than by general robot specifications.

05 | Beyond Instruments: Procedure-Driven Development Requires System-Wide Capabilities

Procedure adaptation does not stop with the instrument itself.

Once a surgical robot begins to cover more specialties and more complex procedures, the requirements extend across the entire system.

These include the coordination of robotic arms, the surgeon console, visualization, energy instruments and supporting surgical devices.

For surgeons, a procedure-specific robotic experience depends on whether these elements can work together consistently.

Instrument replacement needs to be efficient; the robotic arms need sufficient working space; visualization needs to support detailed anatomical identification; and different instruments need to cooperate without adding unnecessary complexity to the workflow.

WEISEBOT is therefore moving toward a broader system-development approach in which instruments, imaging, robotic control and operating-room workflows are considered together.

The company has developed both multi-port and single-port laparoscopic robotic platforms and supporting instruments as part of its product pipeline. Its four-arm multi-port laparoscopic surgical robot has already received market approval in China.

As domestic laparoscopic surgical robots move beyond the initial stage of demonstrating technical feasibility, the next stage of competition is becoming more specific.

The question is increasingly whether a platform can support the details of an actual procedure: whether the right instruments are available, whether they can reach the required anatomy, whether energy devices can be integrated effectively, and whether the complete system fits the surgeon’s workflow.

At the 2026 surgical meeting, WEISEBOT’s latest product development showed one direction this evolution is taking: using procedure requirements to drive instrument design and system iteration.

For the surgical robotics industry, expanding from a general-purpose robotic platform toward procedure-oriented solutions is likely to remain an important part of product development as clinical use becomes broader and more specialized.

September 11, 2026